-transparent.png){kind=logo}
The ability of 1-deprenyl to protect against the parkinsonian effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) has been attributed to the inhibition of conversion of MPTP to MPP+ (1-methyl-4-phenylpyridinium) catalyzed by MAO-B. We report here that deprenyl-treatment in mice has an additional neuroprotective element associated with the rapid metabolization of 1-deprenyl to 1-methamphetamine and 1-amphetamine. 1-Methamphetamine and 1-amphetamine inhibit MPP(+)-uptake into striatal synaptosomes prepared from rats. Post-treatment by 1-deprenyl, 1-methamphetamine, 1-amphetamine (at times when MPTP is no longer present in the striatum of mice) protects against neurotoxicity in C57BL mice by blocking the uptake of MPP+ into dopaminergic neurons, and even against the neurotoxicity induced by 2'CH3-MPTP, which is partly bioactivated by MAO-A. These findings may have clinical implications since deprenyl has recently been found to delay the progression of Parkinson's disease.
I Sziráki, and
V Kardos, and
M Patthy, and
M Pátfalusi, and
J Gaál, and
M Solti, and
E Kollár, and
J Singer
January 2008,
Psychopharmacology,
I Sziráki, and
V Kardos, and
M Patthy, and
M Pátfalusi, and
J Gaál, and
M Solti, and
E Kollár, and
J Singer
January 2005,
Journal of biochemical and molecular toxicology,
I Sziráki, and
V Kardos, and
M Patthy, and
M Pátfalusi, and
J Gaál, and
M Solti, and
E Kollár, and
J Singer
March 2021,
Journal of ethnopharmacology,
I Sziráki, and
V Kardos, and
M Patthy, and
M Pátfalusi, and
J Gaál, and
M Solti, and
E Kollár, and
J Singer
October 1984,
European journal of pharmacology,
I Sziráki, and
V Kardos, and
M Patthy, and
M Pátfalusi, and
J Gaál, and
M Solti, and
E Kollár, and
J Singer
August 1992,
Synapse (New York, N.Y.),
I Sziráki, and
V Kardos, and
M Patthy, and
M Pátfalusi, and
J Gaál, and
M Solti, and
E Kollár, and
J Singer
September 1985,
Neuropharmacology,
I Sziráki, and
V Kardos, and
M Patthy, and
M Pátfalusi, and
J Gaál, and
M Solti, and
E Kollár, and
J Singer
August 1993,
European journal of pharmacology,
I Sziráki, and
V Kardos, and
M Patthy, and
M Pátfalusi, and
J Gaál, and
M Solti, and
E Kollár, and
J Singer
August 1990,
European journal of pharmacology,
I Sziráki, and
V Kardos, and
M Patthy, and
M Pátfalusi, and
J Gaál, and
M Solti, and
E Kollár, and
J Singer
August 1986,
Neuropharmacology,
I Sziráki, and
V Kardos, and
M Patthy, and
M Pátfalusi, and
J Gaál, and
M Solti, and
E Kollár, and
J Singer
July 1999,
Movement disorders : official journal of the Movement Disorder Society,
